High responders are not exempt from detrimental effects of prematurely rising progesterone levels in fresh embryo transfer cycles.


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 29 07 2017
revised: 01 11 2018
accepted: 01 11 2018
pubmed: 24 12 2018
medline: 31 3 2020
entrez: 24 12 2018
Statut: ppublish

Résumé

Are high-responder IVF patients protected from the deleterious effect of prematurely elevated serum progesterone level on the probability of pregnancy? In this retrospective cohort study, 2971 autologous fresh embryo transfer IVF cycles with gonadotrophin-releasing hormone agonist long protocol were analysed to investigate whether the detrimental effect of prematurely rising progesterone levels on clinical pregnancy rate (CPR) varies depending on the magnitude of ovarian response. Nine different evenly spaced intervals were constructed for serum progesterone level on the human chorionic gonadotrophin day (<0.5/0.5-0.9/1-1.4/1.5-1.9/2-2.4/2.5-2.9/3-3.4/3.5-3.9/>4 ng/ml). Then, IVF cycles in each of these intervals were further divided into low (≤3 oocytes), normal (4-15 oocytes) and high responders (≥16 oocytes). The progressive rise of serum progesterone from the <0.5 to the >4 ng/ml interval caused a gradual and continuous decline in the CPR of all three types of ovarian response. The absolute difference in the CPR between the lowest and the highest progesterone groups was not related to the magnitude of ovarian response (-26.6%, -37.7% and -40.7% for the low, normal and high responders, respectively). On multivariate logistic regression analysis, the detrimental effect of progesterone started at 1.5-1.9 ng/ml, 3.0-3.4 ng/ml and 4.0-4.4 ng/ml intervals for the low, normal and high responders, respectively. High responders are not exempt from the detrimental effects of prematurely rising serum progesterone levels but the threshold interval where the detrimental effect begins is higher in the high responders compared with the low and normal responders.

Identifiants

pubmed: 30579821
pii: S1472-6483(18)30589-3
doi: 10.1016/j.rbmo.2018.11.008
pii:
doi:

Substances chimiques

Progesterone 4G7DS2Q64Y
Estradiol 4TI98Z838E
Follicle Stimulating Hormone 9002-68-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

206-215

Informations de copyright

Copyright © 2018 Reproductive Healthcare Ltd. All rights reserved.

Auteurs

Ozgur Oktem (O)

Koc University School of Medicine Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Istanbul, Turkey; American Hospital Women's Health Centre, Assisted Reproduction Unit, Istanbul, Turkey. Electronic address: ooktem@ku.edu.tr.

Kayhan Yakin (K)

Koc University School of Medicine Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Istanbul, Turkey; American Hospital Women's Health Centre, Assisted Reproduction Unit, Istanbul, Turkey.

Sule Yildiz Oguz (SY)

Koc University School of Medicine Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Istanbul, Turkey.

Aycan Isiklar (A)

American Hospital Women's Health Centre, Assisted Reproduction Unit, Istanbul, Turkey.

Basak Balaban (B)

American Hospital Women's Health Centre, Assisted Reproduction Unit, Istanbul, Turkey.

Bulent Urman (B)

Koc University School of Medicine Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Istanbul, Turkey; American Hospital Women's Health Centre, Assisted Reproduction Unit, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH